Target intelligence / Profile preview

Capicua transcriptional repressor pseudogene 10 (CICP10)

Target
CICP10
Molecular classification
Other (Pseudogene, not a transcription factor, enzyme, receptor, etc.)
01

Overview

Capicua transcriptional repressor pseudogene 10 (CICP10) is classified as a human pseudogene—a genomic DNA sequence similar to a known gene, but typically nonfunctional due to mutations that prevent normal protein-coding. It derives from the parental gene CIC, which encodes a high-mobility group box transcriptional repressor with important roles in development and disease. However, CICP10 itself does not code for a protein, does not act as a receptor, enzyme, or drug target, and currently lacks evidence for biological or therapeutic relevance. Pseudogenes like CICP10 may sometimes play regulatory roles as non-coding RNAs in human biology, but there is no direct evidence or established function for CICP10 in the literature at this time. CICP10 is not considered a therapeutic target and is an incorrect target if the query intent was to find a druggable protein or functional receptor. Research and clinical interest should be focused on the functional parental gene, Capicua transcriptional repressor (CIC), for target-related roles.

Other names
CICP10capicua pseudogene 10
02

Mechanism of action

None, as it is a pseudogene

03

Biological functions

Other (Pseudogene, with no current known direct biological function for CICP10 itself)
04

Disease associations

None directly for CICP10; the parental (functional) gene CIC is implicated in cancer and neurodevelopmental diseases, but not the pseudogene itself

Beyond the preview

Go deeper on Capicua transcriptional repressor pseudogene 10 (CICP10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Capicua transcriptional repressor pseudogene 10 (CICP10).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call